 | • レポートコード：GIR-107A14619 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、カルシトニン遺伝子関連ペプチド1型受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カルシトニン遺伝子関連ペプチド1型受容体の種類別市場規模（AFAP-3、AGN-241689、CGRP、エレヌマブ、その他）、用途別市場規模（心血管、代謝障害、歯痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・カルシトニン遺伝子関連ペプチド1型受容体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan Plc、Amgen Inc、Biohaven Pharmaceutical Holding Company Ltd、Eli Lilly and Company、Fortress Biotech Inc、Merck & Co Inc、Teva Pharmaceutical Industries Ltd、Vertex Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AFAP-3、AGN-241689、CGRP、エレヌマブ、その他 ・用途別分析2016年-2026年：心血管、代謝障害、歯痛、その他 ・カルシトニン遺伝子関連ペプチド1型受容体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・カルシトニン遺伝子関連ペプチド1型受容体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・カルシトニン遺伝子関連ペプチド1型受容体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・カルシトニン遺伝子関連ペプチド1型受容体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・カルシトニン遺伝子関連ペプチド1型受容体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Calcitonin Gene Related Peptide Type 1 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Calcitonin Gene Related Peptide Type 1 Receptor size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Calcitonin Gene Related Peptide Type 1 Receptor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Calcitonin Gene Related Peptide Type 1 Receptor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AFAP-3
AGN-241689
CGRP
Erenumab
Others
Market segment by Application can be divided into
Cardiovascular
Metabolic Disorders
Dental Pain
Others
The key market players for global Calcitonin Gene Related Peptide Type 1 Receptor market are listed below:
Allergan Plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Calcitonin Gene Related Peptide Type 1 Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, with price, sales, revenue and global market share of Calcitonin Gene Related Peptide Type 1 Receptor from 2019 to 2021.
Chapter 3, the Calcitonin Gene Related Peptide Type 1 Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Calcitonin Gene Related Peptide Type 1 Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Calcitonin Gene Related Peptide Type 1 Receptor market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Calcitonin Gene Related Peptide Type 1 Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Calcitonin Gene Related Peptide Type 1 Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AFAP-3
1.2.3 AGN-241689
1.2.4 CGRP
1.2.5 Erenumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cardiovascular
1.3.3 Metabolic Disorders
1.3.4 Dental Pain
1.3.5 Others
1.4 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size & Forecast
1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Value (2016-2026))
1.4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume (2016-2026)
1.4.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity Analysis
1.5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Total Production Capacity (2016-2026)
1.5.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
1.6.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
1.6.3 Calcitonin Gene Related Peptide Type 1 Receptor Trends Analysis
2 Manufacturers Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business
2.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen Inc
2.2.1 Amgen Inc Details
2.2.2 Amgen Inc Major Business
2.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.2.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biohaven Pharmaceutical Holding Company Ltd
2.3.1 Biohaven Pharmaceutical Holding Company Ltd Details
2.3.2 Biohaven Pharmaceutical Holding Company Ltd Major Business
2.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.3.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.4.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Fortress Biotech Inc
2.5.1 Fortress Biotech Inc Details
2.5.2 Fortress Biotech Inc Major Business
2.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.5.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck & Co Inc
2.6.1 Merck & Co Inc Details
2.6.2 Merck & Co Inc Major Business
2.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.6.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Teva Pharmaceutical Industries Ltd Details
2.7.2 Teva Pharmaceutical Industries Ltd Major Business
2.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Vertex Pharmaceuticals Inc
2.8.1 Vertex Pharmaceuticals Inc Details
2.8.2 Vertex Pharmaceuticals Inc Major Business
2.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
2.8.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturer
3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Calcitonin Gene Related Peptide Type 1 Receptor
3.4 Market Concentration Rate
3.4.1 Top 3 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer Market Share
3.4.2 Top 6 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer Market Share
3.5 Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Calcitonin Gene Related Peptide Type 1 Receptor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region
4.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2016-2026)
4.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2016-2026)
4.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026)
4.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026)
4.4 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026)
4.5 South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026)
4.6 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Type (2016-2026)
5.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2016-2026)
5.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Application (2016-2026)
6.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2016-2026)
6.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2026)
7.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2026)
7.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country
7.3.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2016-2026)
7.3.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2026)
8.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2026)
8.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country
8.3.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2016-2026)
8.3.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2026)
9.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2026)
9.3 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region
9.3.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2026)
10.2 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2026)
10.3 South America Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country
10.3.1 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2016-2026)
10.3.2 South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2026)
11.2 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2026)
11.3 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country
11.3.1 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Calcitonin Gene Related Peptide Type 1 Receptor Typical Distributors
12.3 Calcitonin Gene Related Peptide Type 1 Receptor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Plc Major Business
Table 5. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 6. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc Major Business
Table 9. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 10. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biohaven Pharmaceutical Holding Company Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Biohaven Pharmaceutical Holding Company Ltd Major Business
Table 13. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 14. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly and Company Major Business
Table 17. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 18. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Fortress Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 20. Fortress Biotech Inc Major Business
Table 21. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 22. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co Inc Major Business
Table 25. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 26. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical Industries Ltd Major Business
Table 29. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 30. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Vertex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Vertex Pharmaceuticals Inc Major Business
Table 33. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 34. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Calcitonin Gene Related Peptide Type 1 Receptor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Calcitonin Gene Related Peptide Type 1 Receptor Production Site of Key Manufacturer
Table 40. Calcitonin Gene Related Peptide Type 1 Receptor New Entrant and Capacity Expansion Plans
Table 41. Calcitonin Gene Related Peptide Type 1 Receptor Mergers & Acquisitions in the Past Five Years
Table 42. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Calcitonin Gene Related Peptide Type 1 Receptor Typical Distributors
Table 101. Calcitonin Gene Related Peptide Type 1 Receptor Typical Customers
List of Figures
Figure 1. Calcitonin Gene Related Peptide Type 1 Receptor Picture
Figure 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type in 2020
Figure 3. AFAP-3
Figure 4. AGN-241689
Figure 5. CGRP
Figure 6. Erenumab
Figure 7. Others
Figure 8. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2020
Figure 9. Cardiovascular
Figure 10. Metabolic Disorders
Figure 11. Dental Pain
Figure 12. Others
Figure 13. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (2016-2026) & (K Pcs)
Figure 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Calcitonin Gene Related Peptide Type 1 Receptor Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
Figure 20. Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
Figure 21. Calcitonin Gene Related Peptide Type 1 Receptor Market Trends
Figure 22. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturer in 2020
Figure 23. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Manufacturer in 2020
Figure 24. Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2016-2026)
Figure 28. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2016-2026)
Figure 29. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026) & (USD Million)
Figure 30. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026) & (USD Million)
Figure 32. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue (2016-2026) & (USD Million)
Figure 34. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2016-2026)
Figure 35. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type (2016-2026)
Figure 36. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 38. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2016-2026)
Figure 39. Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2016-2026)
Figure 41. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 42. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2016-2026)
Figure 43. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2016-2026)
Figure 44. United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2016-2026)
Figure 48. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 49. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2016-2026)
Figure 50. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2016-2026)
Figure 51. Germany Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2016-2026)
Figure 60. China Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2016-2026)
Figure 67. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 68. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2016-2026)
Figure 69. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のグルカゴン様ペプチド2受容体市場 2021：企業別、地域別、種類・用途別 The Glucagon Like Peptide 2 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 世界のアンジオテンシンII受容体拮抗薬用非ペプチド薬市場 2021：企業別、地域別、種類・用途別 The Non-Peptide Drugs of Angiotensin II Receptor Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場 2021：企業別、地域別、種類・用途別 The Glucagon-like Peptide-2 (GLP-2) Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の治療用ペプチド市場 2021：企業別、地域別、種類・用途別 The Therapeutic Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の加齢性黄斑変性症治療薬市場 2021：企業別、地域別、種類・用途別 The Age Related Macular Degeneration Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…